Retrospective Analysis of the Clinical Characteristics of Patients with Breast Cancer Treated with Telomerase Peptide Immunotherapy Combined with Cytotoxic Chemotherapy.
Jong-Yeup KimDong Won YangSangjae KimJong Gwon ChoiPublished in: Breast cancer (Dove Medical Press) (2023)
GV1001 is a relatively safe anticancer vaccine for patients with heavily-treated breast cancer and can to improve the quality of life.